About This Weight Management Therapy and GLP-1 Agonists
Brown GL, Lum RT, Schow SR, Maack C, Vollmer C, Gomez R, Delioukina M, Boulos L, Laxa B, Brown J and Rosen LS
But thats not the world we live in
There is no stomach pumping for an injected medication
Issa, M.D., Ph.D., FAAD explores the emerging therapies dermatology APPs should be watching in bullous pemphigoid and pemphigus vulgaris, including: Type 2 inflammation and dupilumab B cells and autoantibody production The potential role of JAK-STAT signaling These evolving treatment conversations reflect the immunology-focused clinical education coming to Elevate-Derm Summer 2026
However, we also have a constant, low level of circulating GLP-1 even when fasting.[ref][ref] This directly ties into the gut microbiome